Novo Nordisk
(NYSE) NVO
Novo Nordisk Financials at a Glance
Market Cap
$153.56B
Revenue (TTM)
DKK 327.80B
Net Income (TTM)
DKK 121.96B
EPS (TTM)
$4.26
P/E Ratio
10.69
Dividend
$1.80
Beta (Volatility)
0.70 (Low)
Dividend
$1.80
Beta (Volatility)
0.70 (Low)
Price
$44.23
Volume
534,583
Open
$45.40
Price
$44.23
Volume
534,583
Open
$45.40
Previous Close
$45.58
Daily Range
$44.05 - $45.41
52-Week Range
$35.12 - $81.44
Dividend
$1.80
Beta (Volatility)
0.70 (Low)
Price
$44.23
Volume
534,583
Open
$45.40
Previous Close
$45.58
Daily Range
$44.05 - $45.41
52-Week Range
$35.12 - $81.44
NVO News
NVO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Novo Nordisk
Industry
Pharmaceuticals
Sector
Health CareEmployees
68,794
CEO
Maziar Mike Doustdar
Website
www.novonordisk.comHeadquarters
Bagsvaerd, 2880, DK
NVO Financials
Key Financial Metrics (TTM)
Gross Margin
82%
Operating Margin
45%
Net Income Margin
37%
Return on Equity
74%
Return on Capital
44%
Return on Assets
22%
Earnings Yield
9.35%
Dividend Yield
3.95%
Payout Ratio
42.47%
Stock Overview
Market Cap
$153.56B
Shares Outstanding
3.37B
Volume
534.58K
Avg. Volume
17.08M
Financials (TTM)
Gross Profit
DKK 250.28B
Operating Income
DKK 127.66B
EBITDA
DKK 156.73B
Operating Cash Flow
DKK 119.10B
Capital Expenditure
-DKK 90.11B
Free Cash Flow
DKK 28.99B
Cash & ST Invst.
DKK 26.96B
Total Debt
DKK 130.96B
Novo Nordisk Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
DKK 96.82B
+24.0%
Gross Profit
DKK 83.23B
+27.7%
Gross Margin
85.96%
N/A
Market Cap
$153.56B
N/A
Market Cap/Employee
$1.98M
N/A
Employees
77,406
N/A
Net Income
DKK 48.56B
+67.2%
EBITDA
DKK 69.21B
+50.3%
Quarterly Fundamentals
Net Cash
-DKK 124.76B
-61.7%
Accounts Receivable
DKK 100.27B
+16.1%
Inventory
DKK 51.35B
+19.8%
Long Term Debt
DKK 119.17B
+23.7%
Short Term Debt
DKK 27.21B
+21.4%
Return on Assets
21.81%
N/A
Return on Invested Capital
44.45%
N/A
Free Cash Flow
DKK 12.05B
+20.4%
Operating Cash Flow
DKK 24.08B
-2.1%